National Center for Tumor Diseases (NCT)
The National Center for Tumor Diseases (NCT) is a long-term cooperation between the German Cancer Research Center (DKFZ), excellent partners in university medicine and other outstanding research partners at various locations in Germany.
The Federal Ministry of Education and Research (BMBF) confirmed the NCT expansion with four new sites on February 2, 2023. These are Berlin, SüdWest (Tübingen/Stuttgart-Ulm), WERA (Würzburg with partners Erlangen, Regensburg and Augsburg) and West (Cologne/Essen). With the existing sites in Heidelberg and Dresden, a total of six NCT sites are now cooperating with the DKFZ with the aim of sustainably advancing state-of-the-art clinical cancer research in Germany and thereby improving the treatment outcomes and quality of life of cancer patients.
Expansion of the NCT strengthens clinical cancer research
The expanded NCT specifically addresses the major current weaknesses of clinical cancer research in the German research landscape. With its focus on innovative clinical trials, the NCT enables new developments from the laboratory to be tested clinically quickly and to the highest standards, thereby making better diagnostic and treatment options available to patients. Special emphasis will be placed on personalized oncology, patient participation as research partners, rapid and fair patient access to advances in cancer research, and the training of future generations of clinical cancer researchers.
In its final stage, the expanded NCT will be financed with a total of about 100 million euros per year by the BMBF and the respective host state in a ratio of 90:10. In addition, the funding from the host countries will enable the construction of a patient-oriented NCT building at each of the four new sites.
More information: NCT website